Aspect Biosystems of Vancouver 3D Prints Human Cells, Now a Finalist in $300k Competition

Was there ever a point in history where speculation regarding the possibilities of scientific innovation wasn’t greeted by some as implausible in the least, dangerous, or even heretical at worst? So often, it has been the case that the imagination and conjecture intersect and “Eureka!” moments result in scientific advancement, and perhaps in no other field are ethical reservations expressed as vehemently as with biotechnology. Those in the industry generally seem all too aware of the fear and skepticism potentially generated by each breakthrough. Konrad Walus, CEO of Aspect Biosystems, a University of British Columbia-based biotech company, said recently in this regard, when discussing Aspect’s recent breakthrough in 3D-bio-printing, “It’s not science fiction,” he pointed out. “People have done this. They’ve taken all of the cells off of the mechanical part of a heart, and then reseeded new heart cells on there–and it beats.”
(...weiter auf 3dprint.com)